menu
    • menu

    Company profile for Phio Pharmaceuticals

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Phio Pharmaceuticals is focused on developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL™) therapeutic platform. Immunotherapies harness our immune system to restore surveillance of tumors that evade detection – a potential curative medicine. INTASYL™ (formerly known as sd-rxRNA®) therapeutics can be used as a standalone treatment or in combination with ot...
    Phio Pharmaceuticals is focused on developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL™) therapeutic platform. Immunotherapies harness our immune system to restore surveillance of tumors that evade detection – a potential curative medicine. INTASYL™ (formerly known as sd-rxRNA®) therapeutics can be used as a standalone treatment or in combination with other modalities. Our development strategy is to tackle different immune escape mechanisms to treat solid tumors.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Phio PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    257 Simarano Dr Marlborough, Massachusetts 01752
    Telephone
    Telephone
    508-929-3634
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://phiopharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/phio-pharmaceuticals-corp/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/phio_pharma

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Phio Announces Closing of $4 Million Concurrent Registered Direct Offering
    Phio Announces Closing of $4 Million Concurrent Registered Direct Offering

    02 Jun 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/phio-pharmaceuticals-announces-closing-of-4-million-concurrent-registered-direct-offering-and-private-placement-priced-at-the-market-under-nasdaq-rules-301841467.html

    PR NEWSWIRE
    02 Jun 2023
    Share Share
    Phio Announces $4 Million Concurrent Registered Direct Offering
    Phio Announces $4 Million Concurrent Registered Direct Offering

    31 May 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/phio-pharmaceuticals-announces-4-million-concurrent-registered-direct-offering-and-private-placement-priced-at-the-market-under-nasdaq-rules-301838146.html

    PR NEWSWIRE
    31 May 2023
    Share Share
    Phio Pharma Announces Initiation of Collaborative Clinical Trial with PH-762
    Phio Pharma Announces Initiation of Collaborative Clinical Trial with PH-762

    24 May 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/phio-pharmaceuticals-announces-initiation-of-collaborative-clinical-trial-with-ph-762-agonoxs-tumor-infiltrating-lymphocyte-program-agx148-and-providence-cancer-institute-301832848.html

    PR NEWSWIRE
    24 May 2023
    Share Share
    Phio Presents Study Showing INTASYL™ Treatment of NK Cells
    Phio Presents Study Showing INTASYL™ Treatment of NK Cells

    18 May 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/phio-pharmaceuticals-presents-preclinical-study-showing-intasyl-treatment-of-nk-cells-more-than-doubles-ability-to-kill-tumor-cells-301828708.html

    PR NEWSWIRE
    18 May 2023
    Share Share
    Phio Pharmaceuticals receives FDA IND clearance for PH-762 trial
    Phio Pharmaceuticals receives FDA IND clearance for PH-762 trial

    17 May 2023

    // CLINICAL TRIALS ARENA

    https://www.clinicaltrialsarena.com/news/phio-pharmaceuticals-fda-ph-762/

    CLINICAL TRIALS ARENA
    17 May 2023
    Share Share
    Phio Pharma Announces FDA Clearance to Initiate Clinical Trial of PH-762
    Phio Pharma Announces FDA Clearance to Initiate Clinical Trial of PH-762

    16 May 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/phio-pharmaceuticals-announces-fda-clearance-to-initiate-clinical-trial-of-ph-762-for-treatment-of-skin-carcinomas-301825168.html

    PR NEWSWIRE
    16 May 2023
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search